Eight IPOs are scheduled for the week of March 18. The full IPO calendar is available here.
Model N (NYSE:MODN), Life science/tech rev management
Based in Redwood City, CA, Model N scheduled an $88 million IPO with a market cap of $289 million at a price range mid-point of $13.50 for Wednesday, March 20, 2013.
MODN believes it is pioneer in the field of revenue management solutions for life sciences, where it is a major player. Revenue management, however, is not a new area and by 2001 was heavily used in a number of industries.
MODN is going after other verticals but is encountering competition from such major software firms as Oracle and SAP.
Marin Software (NYSE:MRIN), Cloud-based digital ads
San Francisco, CA Marin Software scheduled an $84 million IPO with a market capitalization of $365 million at a price range mid-point of $12 for Friday, March 22, 2013.
MRIN provides Internet ad serving services, just like the DoubleClick subsidiary of Google (NASDAQ:GOOG). MRIN is 55% owned by VCs, pre-IPO. None are selling on the IPO.
West Corp (NASDAQ:WSTC), Voice/data solutions
Based in Omaha, NE, West Corp scheduled a $500 million IPO with a market capitalization of $1,980 million at a price range mid-point of $23.50 for Friday, March 22, 2013.
At the price range mid-point of $23.50 WSTC expects to pay a 3.8% dividend. Founded in 1986, is highly leveraged and will have a negative net worth of $810 million post-IPO.
Tetraphase Pharma (NASDAQ:TTPH), Infection biopharma
Based in Watertown, MA, Tetraphase Pharma scheduled a $75 million IPO with a market capitalization of $179 million at a price range mid-point of $11 for Wednesday, March 20, 2013.
TTPH is a clinical stage biopharmaceutical company using a proprietary chemistry technology to create novel antibiotics for serious and life-threatening multi-drug resistant infections. IPO funds are expected to cover Phase III clinical trial costs of eravacycline through 2015.
Enanta Pharma (NASDAQ:ENTA), Infection biopharma
Based in Watertown, MA, Enanta Pharma scheduled a $60 million IPO with a market capitalization of $252 million at a price range mid-point of $15 for Thursday, March 21, 2013.
ENTA creates small molecule drugs in the infectious disease field with independent research and collaborations with AbbVie Inc. (NYSE:ABBV) $60 billion market cap, and Novartis (NYSE:NVS) $168 billion market cap).
ENTA has been receiving grants and collaboration payments resulting in a positive cash flow.
Aviv REIT (NYSE:AVIV), Skilled nursing facilities REIT
Based in Chicago, IL, Aviv REIT scheduled a $251 million IPO with a market capitalization of $804 million for or Thursday, March 21, 2013.
AVIV is a skilled nursing home REIT. It should not be confused with a mortgage REIT. Recent mortgage REITS have sold off the first day.
H2 Financial Management (HTWO)
HTWO is a blank check company. Blank check companies are very difficult to analyze because they have no operating assets. HTWO expects to IPO Wednesday, March 21, 2013.
Five Oaks Investment (NYSE:OAKS), Mortgage REIT
Based in New York, NY, Five Oaks Investment scheduled an $86 million IPO with a market capitalization of $111 at a price range mid-point of $15 for Friday, March 22, 2013.
OAKS is a residential mortgage backed securities REIT. All recent REITs sold off the 1st day.
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.